Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Amphastar Pharmaceuticals, Inc. (AMPH) vs Phibro Animal Health Corporation (PAHC)

Amphastar Pharmaceuticals, Inc. and Phibro Animal Health Corporation are both Drug Manufacturers Specialty & Generic companies. Phibro Animal Health Corporation is the larger, with a market value of $1.4B against $1.1B — 1.2× the size. Phibro Animal Health Corporation trades at the lower P/E: 14.0× against 15.0×. Phibro Animal Health Corporation grew revenue faster over the last twelve months: 17.1% against 1.02%. Amphastar Pharmaceuticals, Inc. has the higher net margin (10.8% vs 6.57%) and the lower return on invested capital (6.57% vs 11.7%). Across the 22 metrics below, Amphastar Pharmaceuticals, Inc. leads on 11 and Phibro Animal Health Corporation on 11.

Valuation

Metric AMPH PAHC Drug Manufacturers Specialty & Generic median
P/E 15.01 14.00 20.14
P/S 1.56 0.92 2.25
P/B 1.48 3.62 1.90
Price to free cash flow 7.58 141.58 16.54
EV/EBITDA 8.35 8.25 12.29
EV/Sales 2.00 1.35 2.56
Earnings yield 6.66% 7.14% (2.99%)
Free cash flow yield 13.20% 0.71% 0.00%

Profitability

Metric AMPH PAHC Drug Manufacturers Specialty & Generic median
Gross margin 47.68% 33.76% 53.94%
Operating margin 15.66% 12.81% 0.00%
Net margin 10.76% 6.57% 0.00%
Free cash flow margin 20.94% 0.65% 0.00%
Return on equity 10.30% 29.72% (0.40%)
Return on assets 4.68% 6.97% (3.32%)
Return on invested capital 6.57% 11.72% 0.00%

Growth

Metric AMPH PAHC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 1.02% 17.12% 10.01%
EPS growth (last fiscal year) (33.66%) 104.20% —
Revenue growth, 5-year CAGR 15.53% 12.74% 6.74%
Net income growth, 5-year CAGR 133.84% 12.89% 0.00%

Health

Metric AMPH PAHC Drug Manufacturers Specialty & Generic median
Debt to equity 0.80 1.90 0.05
Current ratio 2.40 2.96 2.31
Net debt to EBITDA 1.62 2.62 0.85

Dividend

Metric AMPH PAHC Drug Manufacturers Specialty & Generic median
Dividend yield — 4.19% 1.70%
Payout ratio 0.00 0.59 0.00

Size

Metric AMPH PAHC Drug Manufacturers Specialty & Generic median
Market cap 1.12b 1.38b 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack